Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-22.39	50.29	64.80
Graham Fair Price	-9.57	29.74	32.88
PEG	97.27	< 0.005	-0.23
Price/Book	-1.09	5.43	5.49
Price/Cash Flow	121.69	133.32	60.14
Prices/Earnings	25.27	29.18	23.30
Price/Sales	0.75	17.77	17.64
Price/FCF	121.69	133.32	60.14
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	2.20	0.69	0.67
Operating Margin	43.62	0.28	0.19
ROA	-21.67	0.02	0.02
ROE	0.06	0.05	-21.04
ROIC	0.04	0.05	39.08
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.11	0.02	515.71
Dividends QOQ	< 0.005	< 0.005	-53.29
EBIT QOQ	-0.31	0.44	38.47
EPS QOQ	-1.00	46.00	4487.27
FCF QOQ	-0.04	-0.55	-1335.22
Revenue QOQ	< 0.005	< 0.005	-80.48
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	143.84	153.46	6.69
Days Sales Outstanding (DSO)	62.58	62.91	0.53
Inventory Turnover	0.63	0.59	-6.27
Debt/Capitalization	0.30	0.32	8.52
Quick Ratio	0.82	0.84	3.44
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	28.57	29.08	1.77
Cash	9.52	10.89	14.31
Capex	-0.66	-0.34	49.23
Free Cash Flow	2.61	1.18	-54.59
Revenue	8.89	8.88	-0.08
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.16	1.17	1.21
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.44	1.06	-26.57
Naive Interpretation	Member

06 - Financial Health · Bad

Rating